RxDoctor Payments Data

Clyde Redmond, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Springdale, ARNPI 1700952462

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (43.0%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by J.m. Longyear Manufacturing, LLC at 28.7% of the total. Reporting peaked in 2022 at $1,944 and has fallen 86.5% since, to $262 in 2025. That places this record below the midpoint for thoracic surgery (cardiothoracic vascular surgery) clinicians in AR, where the typical reported total is $3,916.

$3,916in general payments, 2019–2025

Across 30 payments — averaging $130.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • J.m. Longyear Manufacturing, LLC$1K
  • Boston Scientific$1K
  • Cook Incorporated$819
  • Stryker$236
  • Abiomed$206
  • Edwards Lifesciences$147
  • plus $264 from 9 others

What the payments were for

  • Consulting fees$1,12529%
  • Travel & lodging$1,68543%
  • Food & beverage$1,10628%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
J.m. Longyear Manufacturing, LLC2$1,125
Boston Scientific7$1,119
Cook Incorporated1$819
Stryker3$236
Abiomed3$206
Edwards Lifesciences2$147
Abbott3$69
Medtronic(2 entities)2$45
Convatec Inc.1$27
GE HealthCare1$26
W. L. Gore & Associates, Inc.1$26
Johnson & Johnson1$19
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)1$18
Kerecis Limited1$18
Midsouth Orthopedics Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,916 in reported general payments places this provider in the 50th percentile of 48 thoracic surgery (cardiothoracic vascular surgery) providers in Arkansas.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Arkansas

Medicare billing

Part B allowed, 2024
$116,380
Medicare patients
183
Services billed
379

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate14$154
Metoprolol Succinate12$133

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Springdale

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →